The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a higher-dose regimen of semaglutide (Wegovy, Novo Nordisk) for use in a weight-management programme. It follows trial data ...
Medical Supervision Separates Effective Programs From Risky Shortcuts Choosing prescription medication for chronic weight management requires understanding how treatment quality varies dramatically.